These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


76 related items for PubMed ID: 9388485

  • 1. Mechanisms underlying apoptosis induced by combination of 5-fluorouracil and interferon-gamma.
    Koshiji M, Adachi Y, Taketani S, Takeuchi K, Hioki K, Ikehara S.
    Biochem Biophys Res Commun; 1997 Nov 17; 240(2):376-81. PubMed ID: 9388485
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells.
    Kondo M, Nagano H, Wada H, Damdinsuren B, Yamamoto H, Hiraoka N, Eguchi H, Miyamoto A, Yamamoto T, Ota H, Nakamura M, Marubashi S, Dono K, Umeshita K, Nakamori S, Sakon M, Monden M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1277-86. PubMed ID: 15709199
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Combination of 5-FU and IFNalpha enhances IFN signaling pathway and caspase-8 activity, resulting in marked apoptosis in hepatoma cell lines.
    Koike K, Takaki A, Tatsukawa M, Suzuki M, Shiraha H, Iwasaki Y, Sakaguchi K, Shiratori Y.
    Int J Oncol; 2006 Nov 01; 29(5):1253-61. PubMed ID: 17016659
    [Abstract] [Full Text] [Related]

  • 6. Interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line.
    Chu E, Zinn S, Boarman D, Allegra CJ.
    Cancer Res; 1990 Sep 15; 50(18):5834-40. PubMed ID: 1697502
    [Abstract] [Full Text] [Related]

  • 7. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
    Nakamura M, Nagano H, Sakon M, Yamamoto T, Ota H, Wada H, Damdinsuren B, Noda T, Marubashi S, Miyamoto A, Takeda Y, Umeshita K, Nakamori S, Dono K, Monden M.
    J Hepatol; 2007 Jan 15; 46(1):77-88. PubMed ID: 17045692
    [Abstract] [Full Text] [Related]

  • 8. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
    Kim R, Tanabe K, Inoue H, Toge T.
    Int J Oncol; 2002 Mar 15; 20(3):549-55. PubMed ID: 11836567
    [Abstract] [Full Text] [Related]

  • 9. Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma.
    Chu E, Koeller DM, Johnston PG, Zinn S, Allegra CJ.
    Mol Pharmacol; 1993 Apr 15; 43(4):527-33. PubMed ID: 8474431
    [Abstract] [Full Text] [Related]

  • 10. Mechanism of interaction between interferon-gamma and antineoplastic agent on the differentiation of HL-60 promyelocytic cells.
    Kafka M, Dvilansky A, Nathan I.
    Exp Hematol; 1990 Mar 15; 18(3):153-8. PubMed ID: 2105896
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expression level of Bcl-XL critically affects sensitivity of hepatocellular carcinoma cells to LIGHT-enhanced and interferon-gamma-induced apoptosis.
    Li J, Shen F, Wu D, Wei LX, Wang YZ, Shi LH, Zou Y, Wu MC.
    Oncol Rep; 2007 May 15; 17(5):1067-75. PubMed ID: 17390046
    [Abstract] [Full Text] [Related]

  • 15. Multidomain Bcl-2 homolog Bax but not Bak mediates synergistic induction of apoptosis by TRAIL and 5-FU through the mitochondrial apoptosis pathway.
    von Haefen C, Gillissen B, Hemmati PG, Wendt J, Güner D, Mrozek A, Belka C, Dörken B, Daniel PT.
    Oncogene; 2004 Oct 28; 23(50):8320-32. PubMed ID: 15467752
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin.
    Wu XX, Mizutani Y, Kakehi Y, Yoshida O, Ogawa O.
    Cancer Res; 2000 Jun 01; 60(11):2912-8. PubMed ID: 10850437
    [Abstract] [Full Text] [Related]

  • 17. Regrowth of 5-fluorouracil-treated human colon cancer cells is prevented by the combination of interferon gamma, indomethacin, and phenylbutyrate.
    Huang Y, Horvath CM, Waxman S.
    Cancer Res; 2000 Jun 15; 60(12):3200-6. PubMed ID: 10866311
    [Abstract] [Full Text] [Related]

  • 18. Biochemical modulation of 5-fluorouracil with interferon alpha/beta and gamma on murine renal cell carcinoma.
    Ishii T, Marumo K.
    Int J Urol; 2004 Nov 15; 11(11):993-1000. PubMed ID: 15509204
    [Abstract] [Full Text] [Related]

  • 19. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
    Yoshikawa R, Kusunoki M, Yanagi H, Noda M, Furuyama JI, Yamamura T, Hashimoto-Tamaoki T.
    Cancer Res; 2001 Feb 01; 61(3):1029-37. PubMed ID: 11221829
    [Abstract] [Full Text] [Related]

  • 20. Interferon-gamma treatment elevates caspase-8 expression and sensitizes human breast tumor cells to a death receptor-induced mitochondria-operated apoptotic program.
    Ruiz-Ruiz C, Muñoz-Pinedo C, López-Rivas A.
    Cancer Res; 2000 Oct 15; 60(20):5673-80. PubMed ID: 11059759
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.